Research Library

William Martin, director of the Drug Policy Program, and Katharine A. Neill, Alfred C. Glassell, III Postdoctoral Fellow in Drug Policy, testify about the likelihood of marijuana being used as a gateway to harder drugs and the effects of decriminalization on teen use rates before the Texas House Criminal Jurisprudence Committee.

This report suggests the contours of a more comprehensive policy for the United States in the broader Middle East, one that pursues not only important tactical approaches to counter Islamic extremism and terrorism, but also shapes the larger strategic landscape to secure and promote U.S. interests. After defining the challenge for the United States and the international community, the report provides a brief narrative on the rise of ISIS before presenting key policy recommendations for a more strategic approach.

In 1972, a National Commission on Marihuana and Drug Abuse, comprising establishment figures chosen mostly by President Richard Nixon himself, issued a report that declared that “neither the marihuana user nor the drug itself can be said to constitute a danger to public safety” and recommended that Congress and state legislatures decriminalize the use and casual distribution of marijuana and seek means other than prohibition to discourage use. President Nixon ignored the report and Congress declined to consider its recommendations, but during the 40-plus years since its publication, at least 37 states have acted to refashion a crazy-quilt collection of prohibitions, nearly always in the direction favored by the commission. The specifics vary by state, but most reform legislation has followed one of three formulas: decriminalization of marijuana possession, legalization of marijuana for medical use, or legalization of marijuana for adult recreational use. In this issue brief, authors Katharine Neill and William Martin examine the facts and fears surrounding each of these options.

Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”

A new analysis reveals substantial global health gains for AIDS, malaria and neglected tropical diseases that were first targeted by the administration of President George W. Bush in 2003 and then greatly expanded by the Obama administration. Beginning in 2016, an incoming administration will have opportunities to build on this legacy to control and eliminate poverty-related diseases — including those with pandemic potential — and to assert American leadership while being mindful of fiscal constraints.